Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 563-568 , June 2006

Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range

  • Robert V. Mulkern

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Radiology, Children's Hospital, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author. Department of Radiology, Children's Hospital, Boston, MA 02115, USA. Tel.: +1 617 355 3737.
    • ,
  • Agnieszka Szot Barnes

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • ,
  • Steven J. Haker

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • ,
  • Yin P. Hung

      Affiliations

    • Department of Radiology, Children's Hospital, Boston, MA 02115, USA
    • ,
  • Frank J. Rybicki

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • ,
  • Stephan E. Maier

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • ,
  • Clare M.C. Tempany

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA

Received 23 August 2005 ,Accepted 20 December 2005.

References 

  1. American Cancer Society. Cancer facts and figures 2005. Atlanta: American Cancer Society; 2005;
  2. Heuck A, Scheidler J, Sommer B, Graser A, Muller-Lisse UG, Massmann J. MR imaging of prostate cancer. Radiologue. 2003;43:464–473
  3. Mueller-Lisse UG, Mueller-Lisse UL, Haller S, Schneede P, Scheidler JE, Schmeller N, et al. Likelihood of prostate cancer based on prostate-specific antigen density by MRI: retrospective analysis. JCAT. 2002;26:432–437
  4. Tuzel E, Sevinc M, Obuz F, Sade M, Kirkali Z. Is magnetic resonance imaging necessary in the staging of prostate cancer?. Urol Int. 1998;61:227–231
  5. Perrotti M, Han KR, Epstein RE, Kennedy EC, Rabbani F, Badani K, et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study. J Urol. 1999;162:1314–1317
  6. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995;195:385–390
  7. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology. 1993;189:339–352
  8. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am. 2000;38:59–85
  9. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin North Am. 2000;38:31–47
  10. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H. The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am. 2000;38:115–138
  11. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol. 2003;76:617–624
  12. Preziosi P, Orlacchio A, Di Giambattista G, Di Renzi P, Bortolotti L, Fabiano A, et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol. 2003;13:925–930
  13. Engelbrecht MR, Huisman HJ, Laheij RJF, Jager GJ, van Leenders GJLH, Hulsbergen-Van De Kaa CA, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229:248–254
  14. Garcia-Segura JM, Sanchez-Chapado M, Ibarburen C, Viano J, Angulo JC, Gonzalez J, et al. In vivo proton spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology. Magn Reson Imaging. 1999;17:755–765
  15. Kurhanewicz J, Dahiya R, Macdonald JM, Hong Chang L, James TL, Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med. 1993;29:149–157
  16. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7-cm3) spatial resolution. Radiology. 1996;198:795–805
  17. Van der Graaf M, van den Boogert HJ, Jager GJ, Barentsz JO, Heerschap A. Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence-preliminary experience. Radiology. 1999;213:919–925
  18. Yuen JSP, Thng CH, Tan PH, Khin LW, Phee SJL, Xiao D, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol. 2004;171:1482–1486
  19. Hasumi M, Suzuki K, Taketomi A, Matsui H, Yamamoto T, Ito K, et al. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res. 2003;23:4223–4227
  20. Zakian KL, Sircar K, Hricak H, Chen H-N, Shukla-Dave A, Eberhardt S. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005;234:804–814
  21. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med. 2001;46:1054–1058
  22. Liney GP, Turnbull LW, Lowry M, Knowles A, Horsman A. In vivo quantitation of citrate concentration and water T2 relaxation time of the pathologic gland using 1H MRS and MRI. Magn Reson Imaging. 1997;15:1177–1186
  23. Liney GP, Knowles A, Manton D, Turnbull L, Blackband S, Horsman A. Comparison of conventional single echo and multi-echo sequences with a fast spin-echo sequence for quantitative T2-mapping: application to the prostate. J Magn Reson Imaging. 1996;6:603–607
  24. Chan I, Wells W, Mulkern RV, Haker SJ, Zhang J, Zou KH, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted MR imaging; a multi-channel statistical classifier. Med Phys. 2003;30:2390–2398
  25. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002;16:196–200
  26. Gudbjartsson H, Maier SE, Mulkern RV, Morocz IA, Patz S, Jolesz FA. Line scan diffusion imaging. Magn Reson Med. 1996;36:509–518
  27. Maier SE, Gudbjartsson H, Patz S, Hsu L, Lovblad KO, Edelman RR, et al. Line scan diffusion imaging: characterization in healthy subjects and stroke patients. AJR Am J Roentgenol. 1998;171:85–93
  28. Maier SE, Bogner P, Bajzik G, Mamata H, Mamata Y, Repa I, et al. Normal brain and brain tumor: multi-component apparent diffusion coefficient line scan imaging. Radiology. 2001;219:842–849
  29. Mulkern RV, Vajapeyam S, Robertson RL, Caruso PA, Rivkin MJ, Maier SE. Biexponential apparent diffusion coefficient parametrization in adult vs. newborn brain. Magn Reson Imaging. 2001;19:659–668
  30. Graham SJ, Stanchev PL, Bronskill MJ. Criteria for analysis of multicomponent tissue T2 relaxation data. Magn Reson Med. 1996;35:370–378
  31. Istratov AA, Vyvenko OF. Exponential analysis in physical phenomena. Rev Sci Instrum. 1999;70:1233–1257
  32. Cheng KH. In vivo tissue characterization of human brain by chi squares parameter maps: multiparameter proton T2-relaxation analysis. Magn Reson Imaging. 1994;12:1099–1109
  33. Mulkern RV, Gudbjartsson H, Westin CF, Zengingonul HP, Gartner W, Guttmann CRG, et al. Multi-component apparent diffusion coefficients in human brain. NMR Biomed. 1999;12:51–62
  34. Clark CA, Le Bihan D. Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med. 2000;44:852–859
  35. Sukstanskii AL, Yablonskiy DA. Effects of restricted diffusion on MR signal formation. J Magn Reson. 2002;157:92–105
  36. Callaghan PT. Pulsed-gradient spin-echo NMR for planar, cylindrical, and spherical pores under conditions of wall relaxation. J Magn Reson A. 1995;113:53–59
  37. Peled S, Cory CG, Raymond SA, Kirschner DA, Jolesz FA. Water diffusion, T2, and compartmentation in frog sciatic nerve. Magn Reson Med. 1999;42:911–918
  38. Jennings D, Hatton BN, Guo JY, Galons JP, Trouard TP, Raghunand N, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia. 2002;4:255–262
  39. Song SK, Qu ZC, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJH. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res. 2002;62:1555–1558
  40. Dodd NJF, Zhao S. Early detection of tumour response to radiotherapy using MRI. Phys Medica. 1997;13:56–60
  41. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol. 2003;21:1094–1100

PII: S0730-725X(05)00409-1

doi: 10.1016/j.mri.2005.12.008

Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 563-568 , June 2006

Article Tools

* Image Usage & Resolution